Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insight, 2018

  • ID: 4382563
  • Drug Pipelines
  • 52 pages
  • DelveInsight
1 of 4

FEATURED COMPANIES

  • Acorda Life Sciences
  • Astellas Pharma
  • Boehringer Ingelheim
  • Faron Pharmaceuticals
  • Proximagen
  • Sucampo Pharmaceuticals
  • MORE
"Vascular Adhesion Protein 1 (VAP-1) Inhibitors- Pipeline Insight, 2018" report outlays comprehensive Insight of present scenario and growth prospects across Vascular Adhesion Protein 1 (VAP-1) Inhibitors. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 5+ products along with 5+ companies involved.

Products covered by Phase
  • Phase II
  • Pre-clinical
  • Inactive (Dormant and Discontinued)
Overview of pipeline development activities for Vascular Adhesion Protein 1 (VAP-1) Inhibitors

Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details.

Therapeutic segmentation of products for Vascular Adhesion Protein 1 (VAP-1) Inhibitors

The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this mechanism.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by a team of industry experts.

Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
  • Provides an overview of therapeutic pipeline activity for Vascular Adhesion Protein 1 (VAP-1) Inhibitors across the complete product development cycle including all clinical and non-clinical stages
  • It comprises of detailed profiles of Vascular Adhesion Protein 1 (VAP-1) Inhibitors therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
  • Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
  • Coverage of dormant and discontinued pipeline projects across Vascular Adhesion Protein 1 (VAP-1) Inhibitors
Reasons to Buy
  • Establish a comprehensive understanding of the current pipeline scenario across Vascular Adhesion Protein 1 (VAP-1) Inhibitors to formulate effective R&D strategies
  • Assess challenges and opportunities that influence Vascular Adhesion Protein 1 (VAP-1) Inhibitors R&D
  • Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
  • Identify the relationship between the products and use it for target finding, drug repurposing, and precision medicine
  • Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Vascular Adhesion Protein 1 (VAP-1) Inhibitors to enhance and expand business potential and scope
  • Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive and discontinued drugs
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acorda Life Sciences
  • Astellas Pharma
  • Boehringer Ingelheim
  • Faron Pharmaceuticals
  • Proximagen
  • Sucampo Pharmaceuticals
  • MORE
Executive Summary
Overview
Vascular Adhesion Protein-
Structure
Functions
Mechanism of Action
Role in various diseases
Pipeline Therapeutics
Comparative Analysis
Mid Stage Products (Phase II)
Comparative Analysis
ASP8232: Astellas Pharma
Drug Description
Research and Development
(The list continues)
Pre-clinical Stage Products
Comparative Analysis
Therapeutic Assessment
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
Dormant Products
Comparative Analysis
Discontinued Products
Comparative Analysis
Appendix

List of Tables:
Table 1: Total Drugs for VAP-1 Inhibitors
Table 2: Mid Stage Products (Phase II)
Table 3: Pre-clinical Stage Products
Table 4: Assessment by Route of Administration for VAP-1 Inhibitors
Table 5: Assessment by Stage and Route of Administration for VAP-1 Inhibitor
Table 6: Assessment by Molecule Type for VAP-1 Inhibitors
Table 7: Assessment by Stage and Molecule Type
Table 8: Dormant Products
Table 9: Discontinued Products

List of Figures:
Figure 1: Crystal structure of human VAP-1 in complex with pyridazinone inhibitors
Figure 2: Function of VAP-1 in leukocyte adhesion and transmigration
Figure 3: Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Figure 4: Potential causative mechanisms of primary sclerosing cholangitis (PSC)
Figure 5: Role of inflammatory chemokines in NASH
Figure 6: Pipeline VAP-1 Inhibitors
Figure 7: Total Drugs for VAP-1 Inhibitors
Figure 8: Mid Stage Products (Phase II)
Figure 9: Pre-clinical Stage Products
Figure 10: Assessment by Route of Administration
Figure 11: Assessment by Stage and Route of Administration
Figure 12: Assessment by Molecule Type
Figure 13: Assessment by Stage and Molecule Type
Figure 14: Dormant Products
Figure 15: Discontinued Products
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Acorda Life Sciences
  • Astellas Pharma
  • Boehringer Ingelheim
  • Faron Pharmaceuticals
  • Proximagen
  • Sucampo Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll